Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-17-007221)

Filing Details

Accession Number:: 0001209191-17-007221
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-02-02 17:43:34
Reporting Period:: 2017-02-01

Filing Date:: 2017-02-02
Accepted Time:: 2017-02-02 17:43:34
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1401667	Puma Biotechnology Inc.	PBYI	Pharmaceutical Preparations (2834)	770683487

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1678610	Robert Charnas	C/O Puma Biotechnology, Inc. 10880 Wilshire Boulevard, Suite 2150 Los Angeles CA 90024		No	No	No	Yes

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2017-02-01	1,000	$31.80	28,461	No	4	S	Direct
Common Stock	Disposition	2017-02-01	2,008	$31.85	26,453	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 15, 2016.